| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |